CompletedNCT02423824
Liraglutide and Cognitive Difficulties in Bipolarity or Depression
About this title
Read the official source — NCT02423824Interventional studyAges 18–45Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT02423824
- Official title
Show the full official title
Exploring the Neural Substrates of Cognitive Dysfunction With Glucagon-like Peptide-1 Agonists
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Health Network, Toronto, a university.
Who was this study for?
Listed age limits: 18 years to 45 years.
